Author Correction: Cobrotoxin could be an effective therapeutic for COVID-19
Fang Lin1,
Paul F. Reid2,
Zheng-hong Qin1
1 Department of Pharmacology, Laboratory of Aging and Nervous Diseases (SZS0703), College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China
2 Maitland Pharma, Orlando, FL, USA
Correspondence to: Zheng-hong Qin: qinzhenhong@suda.edu.cn,
DOI: 10.1038/s41401-020-00533-z
Advance online: 18 September 2020
Abstract
The authors apologize that they did not declare competing interest in the original article.
Keywords:
